The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Sophia S. Wang

Division of Cancer Epidemiology and Genetics

National Cancer Institute

National Institutes of Health

Department of Health and Human Services

United States of America

[email]@mail.nih.gov

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, United States of America. 2001 - 2009
  • Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Rockville, MD 20852, USA. 2007 - 2009
  • National Cancer Institute, Bethesda, MD 20892-7234, USA. 2003
  • Epidemic Intelligence Service, Division of Applied Public Health Training, Epidemiology Program Office, Centers for Disease Control and Prevention, USA. 2001

References

  1. Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk. Wang, S.S., Purdue, M.P., Cerhan, J.R., Zheng, T., Menashe, I., Armstrong, B.K., Lan, Q., Hartge, P., Kricker, A., Zhang, Y., Morton, L.M., Vajdic, C.M., Holford, T.R., Severson, R.K., Grulich, A., Leaderer, B.P., Davis, S., Cozen, W., Yeager, M., Chanock, S.J., Chatterjee, N., Rothman, N. PLoS. ONE (2009) [Pubmed]
  2. Common genetic variants and risk for non-Hodgkin lymphoma and adult T-cell lymphoma/leukemia in Jamaica. Wang, S.S., Carreon, J.D., Hanchard, B., Chanock, S., Hisada, M. Int. J. Cancer (2009) [Pubmed]
  3. Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer. Wang, S.S., Bratti, M.C., Rodríguez, A.C., Herrero, R., Burk, R.D., Porras, C., González, P., Sherman, M.E., Wacholder, S., Lan, Z.E., Schiffman, M., Chanock, S.J., Hildesheim, A. J. Infect. Dis. (2009) [Pubmed]
  4. Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants. Wang, S.S., Zuna, R.E., Wentzensen, N., Dunn, S.T., Sherman, M.E., Gold, M.A., Schiffman, M., Wacholder, S., Allen, R.A., Block, I., Downing, K., Jeronimo, J., Carreon, J.D., Safaeian, M., Brown, D., Walker, J.L. Cancer Epidemiol. Biomarkers Prev. (2009) [Pubmed]
  5. Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning. Wang, S.S., Smiraglia, D.J., Wu, Y.Z., Ghosh, S., Rader, J.S., Cho, K.R., Bonfiglio, T.A., Nayar, R., Plass, C., Sherman, M.E. Cancer Res. (2008) [Pubmed]
  6. Chromosomal aberrations in peripheral blood lymphocytes and risk for non-Hodgkin lymphoma. Wang, S.S., Davis, S., Hartge, P., Cozen, W., Severson, R.K., Cerhan, J.R., Rothman, N. J. Natl. Cancer Inst. Monographs (2008) [Pubmed]
  7. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors. Wang, S.S., Cozen, W., Cerhan, J.R., Colt, J.S., Morton, L.M., Engels, E.A., Davis, S., Severson, R.K., Rothman, N., Chanock, S.J., Hartge, P. Cancer Res. (2007) [Pubmed]
  8. Genetic variation in catechol-O-methyltransferase (COMT) and obesity in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial. Wang, S.S., Morton, L.M., Bergen, A.W., Lan, E.Z., Chatterjee, N., Kvale, P., Hayes, R.B., Chanock, S.J., Caporaso, N.E. Hum. Genet. (2007) [Pubmed]
  9. Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). Wang, S.S., Slager, S.L., Brennan, P., Holly, E.A., De Sanjose, S., Bernstein, L., Boffetta, P., Cerhan, J.R., Maynadie, M., Spinelli, J.J., Chiu, B.C., Cocco, P.L., Mensah, F., Zhang, Y., Nieters, A., Dal Maso, L., Bracci, P.M., Costantini, A.S., Vineis, P., Severson, R.K., Roman, E., Cozen, W., Weisenburger, D., Davis, S., Franceschi, S., La Vecchia, C., Foretova, L., Becker, N., Staines, A., Vornanen, M., Zheng, T., Hartge, P. Blood (2007) [Pubmed]
  10. Publishing on genes and lymphoma in the era of "big science". Wang, S. Leuk. Lymphoma (2007) [Pubmed]
  11. Pathological characteristics of cervical adenocarcinoma in a multi-center US-based study. Wang, S.S., Sherman, M.E., Silverberg, S.G., Carreon, J.D., Lacey, J.V., Zaino, R., Kurman, R.J., Hildesheim, A. Gynecol. Oncol. (2006) [Pubmed]
  12. Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma. Wang, S.S., Davis, S., Cerhan, J.R., Hartge, P., Severson, R.K., Cozen, W., Lan, Q., Welch, R., Chanock, S.J., Rothman, N. Carcinogenesis (2006) [Pubmed]
  13. Cyclin D1 splice variant and risk for non-Hodgkin lymphoma. Wang, S.S., Cozen, W., Severson, R.K., Hartge, P., Cerhan, J.R., Davis, S., Welch, R., Rothman, N., Chanock, S.J. Hum. Genet. (2006) [Pubmed]
  14. Cervical tissue collection methods for RNA preservation: comparison of snap-frozen, ethanol-fixed, and RNAlater-fixation. Wang, S.S., Sherman, M.E., Rader, J.S., Carreon, J., Schiffman, M., Baker, C.C. Diagn. Mol. Pathol. (2006) [Pubmed]
  15. Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma. Wang, S.S., Cerhan, J.R., Hartge, P., Davis, S., Cozen, W., Severson, R.K., Chatterjee, N., Yeager, M., Chanock, S.J., Rothman, N. Cancer Res. (2006) [Pubmed]
  16. Medication use, medical conditions, and the risk of human papillomavirus infection and subsequent cervical intraepithelial neoplasia 3 among women with mild cytologic abnormalities. Wang, S.S., Schiffman, M. Cancer Epidemiol. Biomarkers Prev. (2005) [Pubmed]
  17. Towards improved biomarker studies of cervical neoplasia: effects of precolposcopic procedures on gene expression patterns. Wang, S.S., Dasgupta, A., Sherman, M.E., Walker, J.L., Gold, M.A., Zuna, R., Sakoda, L., Wacholder, S., Schiffman, M., Baker, C.C. Diagn. Mol. Pathol. (2005) [Pubmed]
  18. Evaluating the risk of cervical precancer with a combination of cytologic, virologic, and visual methods. Wang, S.S., Walker, J.L., Schiffman, M., Solomon, D. Cancer Epidemiol. Biomarkers Prev. (2005) [Pubmed]
  19. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Wang, S.S., Sherman, M.E., Hildesheim, A., Lacey, J.V., Devesa, S. Cancer (2004) [Pubmed]
  20. Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica. Wang, S.S., Schiffman, M., Herrero, R., Carreon, J., Hildesheim, A., Rodriguez, A.C., Bratti, M.C., Sherman, M.E., Morales, J., Guillen, D., Alfaro, M., Clayman, B., Burk, R.D., Viscidi, R.P. Br. J. Cancer (2004) [Pubmed]
  21. Validation of p16INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a population-based cohort in Costa Rica. Wang, S.S., Trunk, M., Schiffman, M., Herrero, R., Sherman, M.E., Burk, R.D., Hildesheim, A., Bratti, M.C., Wright, T., Rodriguez, A.C., Chen, S., Reichert, A., von Knebel Doeberitz, C., Ridder, R., von Knebel Doeberitz, M. Cancer Epidemiol. Biomarkers Prev. (2004) [Pubmed]
  22. Chapter 5: Viral and host factors in human papillomavirus persistence and progression. Wang, S.S., Hildesheim, A. J. Natl. Cancer Inst. Monographs (2003) [Pubmed]
  23. Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10000 women in Costa Rica. Wang, S.S., Schiffman, M., Shields, T.S., Herrero, R., Hildesheim, A., Bratti, M.C., Sherman, M.E., Rodriguez, A.C., Castle, P.E., Morales, J., Alfaro, M., Wright, T., Chen, S., Clayman, B., Burk, R.D., Viscidi, R.P. Br. J. Cancer (2003) [Pubmed]
  24. Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage. Wang, S.S., Hildesheim, A., Gao, X., Schiffman, M., Herrero, R., Bratti, M.C., Sherman, M.E., Barnes, W.A., Greenberg, M.D., McGowan, L., Mortel, R., Schwartz, P.E., Zaino, R.J., Glass, A.G., Burk, R.D., Karacki, P., Carrington, M. Cancer Epidemiol. Biomarkers Prev. (2002) [Pubmed]
  25. Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studies. Wang, S.S., Hildesheim, A., Gao, X., Schiffman, M., Herrero, R., Bratti, M.C., Sherman, M.E., Barnes, W.A., Greenberg, M.D., McGowan, L., Mortel, R., Schwartz, P.E., Zaino, R.J., Glass, A.G., Burk, R.D., Karacki, P., Carrington, M. J. Infect. Dis. (2002) [Pubmed]
  26. Early diagnosis of cystic fibrosis in the newborn period and risk of Pseudomonas aeruginosa acquisition in the first 10 years of life: A registry-based longitudinal study. Wang, S.S., FitzSimmons, S.C., O'Leary, L.A., Rock, M.J., Gwinn, M.L., Khoury, M.J. Pediatrics (2001) [Pubmed]
  27. Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica. Wang, S.S., Wheeler, C.M., Hildesheim, A., Schiffman, M., Herrero, R., Bratti, M.C., Sherman, M.E., Alfaro, M., Hutchinson, M.L., Morales, J., Lorincz, A., Burk, R.D., Carrington, M., Erlich, H.A., Apple, R.J. J. Infect. Dis. (2001) [Pubmed]
 
WikiGenes - Universities